Cellebrite CLBT 深 沪
等待开盘 04-02 09:30:00 美东时间
13.915
+0.135
+0.98%
华盛通- 最 高13.99
- 今 开13.98
- 成交量 41.21万股
- 最 低 13.4722
- 昨 收 13.78
- 总市值 34.71亿
- 52周最高 20.53
- 市盈率 静 44.69
- 换手率 0.17%
- 52周最低 11.76
- 委 比 71.01%
- 总股本 2.49亿
- 历史最高 26.30
- 量 比 0.26
- 振 幅 3.76%
- 历史最低 3.80
- 每 手 1
- 风险率 1.92%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cellebrite Spring Release: New Industry-Leading Device Access and Multi-Cloud Expansion
Now offering access to the widest range of devices and operating systems and expanding availability of Corellium on Google Cloud TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 31, 2026 /P...
03-31 20:30
Cellebrite DI Ltd. CEO Thomas E. Hogan files initial beneficial ownership statement
Cellebrite DI Ltd. CEO Thomas E. Hogan files initial beneficial ownership statement Cellebrite reported an initial statement of beneficial ownership by Thomas Hogan, its chief executive officer and a director. Hogan beneficially owned 693,965 ordinary shares. Hogan also held stock options for 1 mill
03-18 20:26
Cellebrite Files its 2025 Annual Report on Form 20-F
TYSONS CORNER, Va. and PETAH TIKVA, Israel, March 4, 2026 /PRNewswire/ -- Cellebrite (Nasdaq: CLBT), a global leader in AI-powered Digital Investigative and Intelligence solutions for the pu...
03-04 21:30
Cellebrite Completes Acquisition of Drone Forensics Leader SCG Canada, Inc.
Addition of Unmanned Aerial Vehicle (UAV) forensic capabilities extends Cellebrite's AI-powered platform to one of the fastest-growing data sources in defense and public safety TYSONS CORNER...
03-02 21:30
美股大行评级 | AppLovin评级分歧大！高盛等4家下调，韦德布什上调；HubSpot、休曼纳公司、Shopify、Unity、Paycom Software等遭多家大行下调目标价
今日重点评级关注：HC Wainwright & Co.：维持NovoCure"买入"评级，目标价从39美元升至47美元；HC Wainwright & Co.：维持Agios制药"买入"评级，目标价从62美元升至65美元
02-13 15:30
Needham Maintains Buy on Cellebrite DI, Lowers Price Target to $18
Needham analyst Mike Cikos maintains Cellebrite DI (NASDAQ:CLBT) with a Buy and lowers the price target from $24 to $18.
02-12 21:02
Cellebrite DI Sees Q1 Sales $126.000M-$128.000M vs $130.637M Est
Cellebrite DI (NASDAQ:CLBT) sees Q1 sales of $126.000 million-$128.000 million vs $130.637 million analyst estimate.
02-11 20:02
Cellebrite DI: Q4 Earnings Insights
Cellebrite DI (NASDAQ:CLBT) announced its Q4 earnings on Wednesday, February 11...
02-11 20:02
Earnings Scheduled For February 11, 2026
Companies Reporting Before The Bell • SiteOne Landscape Supply (NYSE:SITE) is p...
02-11 19:11
Security Tech Check-In: Analyst Insights From 12 Companies Ahead Of The 'Quiet Period'
Needham analysts met with 12 companies before quiet period. Ratings and price targets by analyst Mike Cikos.
2025-12-19 03:38
